Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to a new study. There were no infections among the young women and girls who received the ...

Is the AIDS-vaccine syringe half full — or virtually empty? That’s the question researchers continue to contemplate following the release on Tuesday of the full trial data of a vaccine tested against ...

Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat the disease’s ongoing spread throughout the country. Over 100,000 people ...

More than 40 years of AIDS research has led to significant advancements in treatment and prevention. Drugs to treat the infection continued to improve, as did patient outcomes. But now there's another ...

HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few ...

An AIDS vaccine has been shown to reduce the risk of HIV infection in humans for the first time, a significant advance in a field of research that has long been stymied by failure. The $105 million, ...

A study billed as the last chance to develop an HIV vaccine this decade has been shut down, investigators announced Wednesday at a conference in Harare, Zimbabwe. The trial, known as PrEPVacc, was ...

In 1994, the Rockefeller Foundation convened an international meeting of AIDS researchers, vaccinologists, public health officials, and representatives from philanthropic organizations in Bellagio, ...

ATLANTA - Doctors should consider giving a daily AIDS drug to another high-risk group to help prevent infections - people who shoot heroin, methamphetamines or other injection drugs, U.S. health ...

From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree ...

The Ebonyi State government has officially launched the Long-Lasting Injectable Pre–Exposure Prophylaxis, Lenacapavir (LEN ...